Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**2-Mercaptobenzothiazole (MBT)** is an organosulfur compound with the formula C7H5NS2. It appears as a pale yellow crystalline solid with a disagreeable odor and is primarily used as an industrial chemical rather than a pharmaceutical drug. Its main applications are as a vulcanization accelerator in the rubber industry, corrosion inhibitor for metals, biocide in water treatment processes, and reagent in analytical chemistry for detecting heavy metals[4][5][7]. In biological contexts, MBT has been shown to inhibit thyroid peroxidase enzyme activity in vitro—a key enzyme necessary for thyroid hormone synthesis[1]. It can also act as a skin sensitizer and standardized chemical allergen by increasing histamine release[1][2]. While it has potential antifungal and antibacterial properties that have led to some research interest in pharmaceuticals, its primary use remains industrial.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-Mercaptobenzothiazole.